טוען...

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Vortioxetine is approved for the treatment of adults with major depressive disorder. This open-label extension (OLE) study evaluated the safety and tolerability of vortioxetine in the long-term treatment of major depressive disorder patients, as well as evaluated its effectiveness using measures of...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int Clin Psychopharmacol
Main Authors: Jacobsen, Paula L., Harper, Linda, Chrones, Lambros, Chan, Serena, Mahableshwarkar, Atul R.
פורמט: Artigo
שפה:Inglês
יצא לאור: Lippincott Williams And Wilkins 2015
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4525811/
https://ncbi.nlm.nih.gov/pubmed/26020712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000081
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!